Calypso's latest venture round brings in $50mm
Calypso Medical Technologies (implantable devices for tumor localization and monitoring) raised $48.4mm through a venture round co-led by founding backer Frazier Healthcare Venture and new investor Skyline Ventures. First-time buyer InterWest Partners also participated, along with existing investors Bay City Capital, Versant Ventures, BB Biotech, Arnerich Massena & Associates, Apothecary Capital, RiverVest Ventures, Merlin Nexus, Early Bird Ventures, Glenview Capital Management, Integra Ventures, AEOW, Kaiser Permanente Ventures, Mosaix Ventures, SB Life Science Ventures, Mitsui & Co. Venture Partners, Rockport Ventures, and 21 other investors.
- Medical Devices
- Implantable Devices
- Monitoring Equipment & Devices
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.